Promoter polymorphism in fibroblast growth factor 1 gene increases risk of definite Alzheimer's disease

Biochemical and Biophysical Research Communications

Volumn 321, Issue 2, 2004, Pages 320-323

  Yamagata, Hidehisa ^a   Chen, Yusen ^a   Akatsu, Hiroyasu ^b   Kamino, Kouzin ^c   Ito, Jin Ichi ^d   Yokoyama, Shinji ^d   Yamamoto, Takayuki ^b   Kosaka, Kenji ^b   Miki, Tetsuro ^a   Kondo, Ikuko ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fukushimura Hospital   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

APOE; Association study; Definite Alzheimer's disease; Fibroblast growth factor 1 gene; Promoter polymorphism; Risk factor

Indexed keywords

APOLIPOPROTEIN E4; FIBROBLAST GROWTH FACTOR 1; APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; AUTOPSY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; AUTOPSY; FIBROBLAST GROWTH FACTOR 1; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 3242814593     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.06.142     Document Type: Article

References (20)

1. C.H. Kawas and R. Katzman The epidemiology of dementia and Alzheimer disease R.D. Terry R. Katzman K.L. Bick S.S. Sisodia Alzheimer disease second ed. 1999 Lippincott Williams & Wilkins Philadelphia 95 116
2. D.J. Selkoe Alzheimer’s disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
3. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944
4. F.P. Eckenstein Fibroblast growth factors in the nervous system J. Neurobiol. 25 1994 1467 1480
5. Z. Guo and M. Mattson Neurotrophic factors protect cortical synaptic terminals against amyloid-and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function Cereb. Cortex 10 2000 50 57
6. V. Thorns and E. Masliah Evidence for neuroprotective effects of acidic fibroblast growth factor in Alzheimer disease J. Neuropathol. Exp. Neurol. 58 1999 296 306
7. I.P. Everall, G. Trillo-Pazos, C. Bell, M. Mallory, V. Sanders and E. Masliah Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection J. Neuropathol. Exp. Neurol. 60 2001 293 301
8. I. Tooyama, H. Akiyama, P.L. McGeer, Y. Hara, O. Yasuhara and H. Kimura Acidic fibroblast growth factor-like immunoreactivity in brain of Alzheimer patients Neurosci. Lett. 121 1991 155 158
9. H. Kimura, I. Tooyama and P.L. McGeer Acidic FGF expression in the surroundings of senile plaques Tohoku J. Exp. Med. 174 1994 279 293
10. S. Ueno, J. Ito, Y. Nagayasu, T. Furukawa and S. Yokoyama An acidic fibroblast growth factor-like factor secreted into the brain cell culture medium upregulates APOE synthesis, HDL secretion and cholesterol metabolism in rat astrocytes Biochim. Biophys. Acta 1589 2002 261 272
11. T. Tada, J. Ito, M. Asai and S. Yokoyama Fibroblast growth factor 1 is produced prior to apolipoprotein E in the astrocytes after cryo-injury of mouse brain Neurochem. Int. 45 2004 23 30
12. V. Thorns, F. Licastro and E. Masliah Locally reduced levels of acidic FGF lead to decreased expression of 28-kDa calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease Neuropathology 21 2001 203 211
13. M.F. Folstein, S.E. Folstein and P.R. McHugh Mini-mental state, a practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 1975 189 198
14. H. Akatsu, M. Takahashi, N. Matsukawa, Y. Ishikawa, N. Kondo, T. Sato, H. Nakazawa, T. Yamada, H. Okada, T. Yamamoto and K. Kosaka Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital J. Neurol. Sci. 196 2002 63 69
15. M. Matsubara, H. Yamagata, K. Kamino, T. Nomura, K. Kohara, I. Kondo and T. Miki Genetic association between Alzheimer disease and the alpha-synuclein gene Dement. Geriatr. Cogn. Disord. 12 2001 106 109
16. J. Sambrook, E.F. Fritsch and T. Maniatis Molecular Cloning: A Laboratory Manual second ed. 1989 Cold Spring Harbor Laboratory Press New York 9 14
17. T. Yoneyama, H. Kasuya, H. Onda, H. Akagawa, N. Jinnai, T. Nakajima, T. Hori and I. Inoue Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm J. Hum. Genet 48 2003 309 314
18. R.L. Myers, R.A. Payson, M.A. Chotani, L.L. Deaven and I.M. Chiu Gene structure and differential expression of acidic fibroblast growth factor mRNA: identification and distribution of four different transcripts Oncogene 8 1993 341 349
19. R.A. Payson, M.A. Chotani and I.M. Chiu Regulation of a promoter of the fibroblast growth factor 1 gene in prostate and breast cancer cells J. Steroid Biochem. Mol. Biol. 66 1998 93 103
20. I.M. Chiu, K. Touhalisky and C. Baran Multiple controlling mechanisms of FGF1 gene expression through multiple tissue-specific promoters Prog. Nucleic Acid Res. Mol. Biol. 70 2001 155 174